Pity about BresaGen
Article Abstract:
BresaGen is Australia's small biotechnology company that is internationally recognized science and valuable intellectual property, but runs low money in a rising stock market and ends up in administration. John Smeaton, the president and chief executive and who was the driving force in the development of BresaGen for 17 years, plans to restructure BresaGen's operations.
Publication Name: Business Review Weekly
Subject: Business, general
ISSN: 0727-758X
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
A leaner, happier Autogen
Article Abstract:
Australian biotechnology firm Autogen is recovering from management turmoil brought on by the departure of managing director Joesph Gutnick. Autogen is cutting costs and plans to be self-funding, and the genetics researcher may be seeking acquisition targets.
Publication Name: Business Review Weekly
Subject: Business, general
ISSN: 0727-758X
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
The genome gold rush
Article Abstract:
The completion of the Human Genome Project will have important implications for the biotechnology industry as firms compete to take advantage of the research.
Publication Name: Business Review Weekly
Subject: Business, general
ISSN: 0727-758X
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: EBay wraps its wares in a catalog, hoping shoppers turn to its pages. Expert team monitors Web's security holes
- Abstracts: Long-distance rates will stay at present level, analysts believe. WorldCom officials want to sell parts of Sprint
- Abstracts: Water utility industry. Water utlitiy industry
- Abstracts: High hopes. Minchin hoses down CEOs. RBA attracts interest in difficult period
- Abstracts: Planes, tankers and the Petroulias GST scheme. A big year for the taxman. The taxman, the actor and the phantoms